Principal
Craft VenturesCheck size: No Kindle-specific check range is public. Craft's live portfolio attributes her to growth, Series A and Series B investments, but those stage labels do not reveal individual allocation authority or check size. Confirm current vehicle, ownership and lead/co-invest posture directly.
Kindle invests where AI or advanced technology becomes a mission-critical operating layer in large, regulated or technically demanding markets. Her attributed work spans AI medical knowledge, regulatory compliance, autonomous defense systems, biotechnology and neurotechnology, with a recurring emphasis on trusted domain data, expert workflows, demonstrable adoption and products capable of becoming the intelligence layer for an industry.
Exceptional adoption among domain professionals, proprietary or defensible data, products embedded in consequential workflows, strong technical teams, clear customer value, credible accuracy and safety, large regulated markets and founders who can pair research depth with commercial execution.
No personal pass list is public. Her published investment work implies weak fit for generic AI wrappers without workflow ownership, high-stakes products lacking trust and validation, defense or healthcare claims without domain access, undifferentiated enterprise software and growth rounds unsupported by durable adoption. These are reasoned inferences, not quotations.
Lead with the high-value workflow, end user and why existing tools fail; show live product, adoption, frequency, retention and measurable outcomes; explain proprietary data, model or systems advantage; cover safety, evaluation, regulation and procurement; then state stage, round and milestones. For healthcare or defense, bring direct practitioner evidence and deployment detail.
Define the consequential decision, current expert process, acceptable error rate and proof that users trust the product in daily work.
Assess whether proprietary data, feedback loops, integrations and expert usage compound model and product performance.
Prioritize repeated usage, retention and measurable outcomes from real practitioners over impressive but isolated model demonstrations.
Map validation, safety, procurement, security, regulation, liability and human oversight required to scale in healthcare, defense or compliance.
Clinical AI earns trust by organizing medical knowledge around physicians' high-stakes decisions and proving repeated, large-scale practitioner adoption.
Regulatory AI agents can deconstruct complex rules and automate compliance review, turning a costly expert workflow into faster and more effective software-driven operations.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
SF-based investor focused on AI, enterprise SaaS, and defense. Previously an investor at Accel on growth-stage enterprise software, fintech, and AI. Began her career at Goldman Sachs in technology investment banking.